Mounjaro will soon be available as a weight loss treatment on the NHS. Here’s what that means for patients
The weight loss jab Mounjaro will soon be made available to nearly a quarter of a million NHS patients, according to proposals made by the National Institute for Health and Care Excellence (Nice). Previously, it was only available on the NHS for patients with diabetes.
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia
(MedPage Today) — All doses of the diabetes and weight management injectable tirzepatide (Mounjaro, Zepbound) were taken off the FDA’s shortage list. (Reuters)
This prompted a compounding group to sue the FDA for removing the drug from said list…
3 reasons behind the rise in breast cancer, including some you can control
There’s a troubling rise in breast cancer in women under the age of 50, an American Cancer Society report shows, but there are things you can do to help lower your risk.
Breast cancer rates rising rapidly in women under 50, new report shows
A new American Cancer Society report reveals that breast cancer rates in women under 50 have risen by 1.4% annually since 2012, double the rate seen in older women. Asian American and Pacific Islander women have experienced the largest increase since 2000. CBS News chief medical correspondent Dr. Jon LaPook joins “CBS Mornings Plus” to talk about the concerning trends.
ACS: Breast Cancer Incidence Rising, Disparities Persist
The biennial breast cancer update from the ACS reported an increase in diagnoses, especially among younger women, as well as disparities in survival outcomes. Medscape Medical News
Study finds common breast cancer treatments may speed aging process
A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center has revealed that common breast cancer treatments, including chemotherapy, radiation, and surgery, may accelerate the biological aging process in breast cancer survivors.
Reproductive Risk Factor Patterns in Caribbean Women With Breast Cancer
This cross-sectional study examines changes over 4 decades in factors related to reproduction in women in Caribbean countries with a diagnosis of invasive breast cancer.
Expanded Medicare Coverage of Antiobesity Drugs May Cost Billions Each Year
Expanding Medicare coverage of a glucagon-like peptide-1 (GLP-1) receptor agonist to treat obesity could increase annual spending by several billion dollars, a study in Health Affairs found.
Hormonal Contraception Linked to Increased Breast Cancer Risk in BRCA1 Carriers
(MedPage Today) — Carriers of the BRCA1 cancer gene had a significantly increased risk of breast cancer if they used hormonal contraception (HC), pooled cohort data showed.
Breast cancer risk increased by 29% in BRCA1 carriers who reported any…
Analysis reveals higher cost of anti-obesity drugs compared to surgery
The cost of taking weekly injections of popular anti-obesity medications liraglutide (Saxenda) or semaglutide (Wegovy) exceeds that of metabolic and bariatric surgery in less than a year, according to a recent analysis published in the journal Surgical Endoscopy.